These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22126897

  • 41. Colistin: an antimicrobial for the 21st century?
    Stein A, Raoult D.
    Clin Infect Dis; 2002 Oct 01; 35(7):901-2. PubMed ID: 12228836
    [No Abstract] [Full Text] [Related]

  • 42. In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany.
    Schülin T.
    J Antimicrob Chemother; 2002 Feb 01; 49(2):403-6. PubMed ID: 11815589
    [Abstract] [Full Text] [Related]

  • 43. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H, Ongen B, Erturan Z, Salcioğlu M.
    Jpn J Infect Dis; 2007 May 01; 60(2-3):82-6. PubMed ID: 17515637
    [Abstract] [Full Text] [Related]

  • 44. Development of a rapid colorimetric time-kill assay for determining the in vitro activity of ceftazidime and tobramycin in combination against Pseudomonas aeruginosa.
    Moriarty F, Elborn S, Tunney M.
    J Microbiol Methods; 2005 May 01; 61(2):171-9. PubMed ID: 15722142
    [Abstract] [Full Text] [Related]

  • 45. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
    Beaudoin T, Aaron SD, Giesbrecht-Lewis T, Vandemheen K, Mah TF.
    Can J Microbiol; 2010 Jul 01; 56(7):548-57. PubMed ID: 20651854
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Combination testing of colistin with telavancin and daptomycin.
    Milne KE, Gould IM.
    J Antimicrob Chemother; 2014 Dec 01; 69(12):3440-1. PubMed ID: 25077490
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. The clinical use of colistin in patients with cystic fibrosis.
    Beringer P.
    Curr Opin Pulm Med; 2001 Nov 01; 7(6):434-40. PubMed ID: 11706322
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Pseudomonas aeruginosa colonization in Turin CF center. Microbiological and therapeutic observations].
    Castello M, Mari C.
    Minerva Pediatr; 1995 May 01; 47(5):175-85. PubMed ID: 7643819
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Mechanism of amikacin resistance in Pseudomonas aeruginosa isolates from patients with cystic fibrosis.
    Hurley JC, Miller GH, Smith AL.
    Diagn Microbiol Infect Dis; 1995 Aug 01; 22(4):331-6. PubMed ID: 8582138
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Antibiotic tolerance induced by lactoferrin in clinical Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Andrés MT, Viejo-Diaz M, Pérez F, Fierro JF.
    Antimicrob Agents Chemother; 2005 Apr 01; 49(4):1613-6. PubMed ID: 15793153
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.